Finnish company Oura, known for its health-monitoring smart rings, has raised $900 million in a new funding round led by Fidelity Management & Research Company (FMR Co.). The deal brings Oura’s valuation to $11 billion.
Nvidia has announced that the DGX Spark, its new compact AI computer boasting a staggering 1-petaflop performance, is now available for order. Priced at $4,000, it’s designed to fit comfortably on a desk.
Scientists at the University of Massachusetts Amherst have developed the first artificial neuron capable of directly “communicating” with living cells — all without the need for any external signal amplification devices.
The U.S. Food and Drug Administration (FDA) has announced the most serious type of market recall (Class I) for Impella heart pump controllers manufactured by a company owned by Johnson & Johnson, citing discovered cybersecurity flaws.
The U.S. Senate has passed an amendment to the defense budget bill banning federal funding for projects involving Chinese biotechnology companies deemed a threat to national security.
OpenAI and Broadcom have entered into a partnership that will result in the first dedicated AI chips in OpenAI’s history. The company aims to reduce its reliance on external chip manufacturers — and the market response has been overwhelmingly positive.
Videos
This conversation looks at a startup tackling a precise operational choke point: medication-adherence outreach in U.S. ambulatory care and pharmacy settings. Instead of promising to “fix the EMR,” Rivvi positions itself around the messy, human workflows that sit beside it – call lists, spreadsheets, payer feeds – and uses conversational AI to turn those inputs into structured, attributable actions.
A multi-pathology AI “copilot” that analyzes chest/abdomen CTs. It detects, segments, and packages results for over 20 acute pathologies in parallel targeting emergency department. We asked the founder of xAID, Kirill Lopatin, to walk us through the system’s core workflow.